175 related articles for article (PubMed ID: 37516111)
1. Potent cross-neutralization of respiratory syncytial virus and human metapneumovirus through a structurally conserved antibody recognition mode.
Wen X; Suryadevara N; Kose N; Liu J; Zhan X; Handal LS; Williamson LE; Trivette A; Carnahan RH; Jardetzky TS; Crowe JE
Cell Host Microbe; 2023 Aug; 31(8):1288-1300.e6. PubMed ID: 37516111
[TBL] [Abstract][Full Text] [Related]
2. A Potent Neutralizing Site III-Specific Human Antibody Neutralizes Human Metapneumovirus
Bar-Peled Y; Diaz D; Pena-Briseno A; Murray J; Huang J; Tripp RA; Mousa JJ
J Virol; 2019 Oct; 93(19):. PubMed ID: 31292250
[TBL] [Abstract][Full Text] [Related]
3. Human antibody recognition of antigenic site IV on Pneumovirus fusion proteins.
Mousa JJ; Binshtein E; Human S; Fong RH; Alvarado G; Doranz BJ; Moore ML; Ohi MD; Crowe JE
PLoS Pathog; 2018 Feb; 14(2):e1006837. PubMed ID: 29470533
[TBL] [Abstract][Full Text] [Related]
4. A Pan-Pneumovirus vaccine based on immunodominant epitopes of the fusion protein.
Huang J; Miller RJ; Mousa JJ
Front Immunol; 2022; 13():941865. PubMed ID: 36003370
[TBL] [Abstract][Full Text] [Related]
5. Profiling of hMPV F-specific antibodies isolated from human memory B cells.
Xiao X; Fridman A; Zhang L; Pristatsky P; Durr E; Minnier M; Tang A; Cox KS; Wen Z; Moore R; Tian D; Galli JD; Cosmi S; Eddins MJ; Sullivan NL; Yan X; Bett AJ; Su HP; Vora KA; Chen Z; Zhang L
Nat Commun; 2022 May; 13(1):2546. PubMed ID: 35538099
[TBL] [Abstract][Full Text] [Related]
6. A broadly neutralizing human monoclonal antibody exhibits in vivo efficacy against both human metapneumovirus and respiratory syncytial virus.
Schuster JE; Cox RG; Hastings AK; Boyd KL; Wadia J; Chen Z; Burton DR; Williamson RA; Williams JV
J Infect Dis; 2015 Jan; 211(2):216-25. PubMed ID: 24864121
[TBL] [Abstract][Full Text] [Related]
7. Characterization of potent RSV neutralizing antibodies isolated from human memory B cells and identification of diverse RSV/hMPV cross-neutralizing epitopes.
Xiao X; Tang A; Cox KS; Wen Z; Callahan C; Sullivan NL; Nahas DD; Cosmi S; Galli JD; Minnier M; Verma D; Babaoglu K; Su H; Bett AJ; Vora KA; Chen Z; Zhang L
MAbs; 2019; 11(8):1415-1427. PubMed ID: 31402751
[TBL] [Abstract][Full Text] [Related]
8. Cross-neutralization of four paramyxoviruses by a human monoclonal antibody.
Corti D; Bianchi S; Vanzetta F; Minola A; Perez L; Agatic G; Guarino B; Silacci C; Marcandalli J; Marsland BJ; Piralla A; Percivalle E; Sallusto F; Baldanti F; Lanzavecchia A
Nature; 2013 Sep; 501(7467):439-43. PubMed ID: 23955151
[TBL] [Abstract][Full Text] [Related]
9. Structural basis for respiratory syncytial virus and human metapneumovirus neutralization.
Miller RJ; Mousa JJ
Curr Opin Virol; 2023 Aug; 61():101337. PubMed ID: 37544710
[TBL] [Abstract][Full Text] [Related]
10. Structure-based design of a single-chain triple-disulfide-stabilized fusion-glycoprotein trimer that elicits high-titer neutralizing responses against human metapneumovirus.
Ou L; Chen SJ; Teng IT; Yang L; Zhang B; Zhou T; Biju A; Cheng C; Kong WP; Morano NC; Stancofski ED; Todd JP; Tsybovsky Y; Wang S; Zheng CY; Mascola JR; Shapiro L; Woodward RA; Buchholz UJ; Kwong PD
PLoS Pathog; 2023 Sep; 19(9):e1011584. PubMed ID: 37738240
[TBL] [Abstract][Full Text] [Related]
11. Cross-protective antibodies against common endemic respiratory viruses.
Cabán M; Rodarte JV; Bibby M; Gray MD; Taylor JJ; Pancera M; Boonyaratanakornkit J
Nat Commun; 2023 Feb; 14(1):798. PubMed ID: 36781872
[TBL] [Abstract][Full Text] [Related]
12. Respiratory Syncytial Virus and Human Metapneumovirus Infections in Three-Dimensional Human Airway Tissues Expose an Interesting Dichotomy in Viral Replication, Spread, and Inhibition by Neutralizing Antibodies.
Kinder JT; Moncman CL; Barrett C; Jin H; Kallewaard N; Dutch RE
J Virol; 2020 Sep; 94(20):. PubMed ID: 32759319
[TBL] [Abstract][Full Text] [Related]
13. Structural basis for antibody cross-neutralization of respiratory syncytial virus and human metapneumovirus.
Wen X; Mousa JJ; Bates JT; Lamb RA; Crowe JE; Jardetzky TS
Nat Microbiol; 2017 Jan; 2():16272. PubMed ID: 28134915
[TBL] [Abstract][Full Text] [Related]
14. Respiratory syncytial virus fusion nanoparticle vaccine immune responses target multiple neutralizing epitopes that contribute to protection against wild-type and palivizumab-resistant mutant virus challenge.
Gilbert BE; Patel N; Lu H; Liu Y; Guebre-Xabier M; Piedra PA; Glenn G; Ellingsworth L; Smith G
Vaccine; 2018 Dec; 36(52):8069-8078. PubMed ID: 30389195
[TBL] [Abstract][Full Text] [Related]
15. Characterization of Epitope-Specific Anti-Respiratory Syncytial Virus (Anti-RSV) Antibody Responses after Natural Infection and after Vaccination with Formalin-Inactivated RSV.
Widjaja I; Wicht O; Luytjes W; Leenhouts K; Rottier PJM; van Kuppeveld FJM; Haijema BJ; de Haan CAM
J Virol; 2016 Jul; 90(13):5965-5977. PubMed ID: 27099320
[TBL] [Abstract][Full Text] [Related]
16. Identification of antibody neutralization epitopes on the fusion protein of human metapneumovirus.
Ulbrandt ND; Ji H; Patel NK; Barnes AS; Wilson S; Kiener PA; Suzich J; McCarthy MP
J Gen Virol; 2008 Dec; 89(Pt 12):3113-3118. PubMed ID: 19008400
[TBL] [Abstract][Full Text] [Related]
17. Isolation and characterization of monoclonal antibodies which neutralize human metapneumovirus in vitro and in vivo.
Ulbrandt ND; Ji H; Patel NK; Riggs JM; Brewah YA; Ready S; Donacki NE; Folliot K; Barnes AS; Senthil K; Wilson S; Chen M; Clarke L; MacPhail M; Li J; Woods RM; Coelingh K; Reed JL; McCarthy MP; Pfarr DS; Osterhaus AD; Fouchier RA; Kiener PA; Suzich JA
J Virol; 2006 Aug; 80(16):7799-806. PubMed ID: 16873237
[TBL] [Abstract][Full Text] [Related]
18. Structural basis for ultrapotent antibody-mediated neutralization of human metapneumovirus.
Banerjee A; Huang J; Rush SA; Murray J; Gingerich AD; Royer F; Hsieh CL; Tripp RA; McLellan JS; Mousa JJ
Proc Natl Acad Sci U S A; 2022 Jun; 119(25):e2203326119. PubMed ID: 35696580
[TBL] [Abstract][Full Text] [Related]
19. Engineering, Structure and Immunogenicity of the Human Metapneumovirus F Protein in the Postfusion Conformation.
Más V; Rodriguez L; Olmedillas E; Cano O; Palomo C; Terrón MC; Luque D; Melero JA; McLellan JS
PLoS Pathog; 2016 Sep; 12(9):e1005859. PubMed ID: 27611367
[TBL] [Abstract][Full Text] [Related]
20. A Chimeric Pneumovirus Fusion Protein Carrying Neutralizing Epitopes of Both MPV and RSV.
Wen X; Pickens J; Mousa JJ; Leser GP; Lamb RA; Crowe JE; Jardetzky TS
PLoS One; 2016; 11(5):e0155917. PubMed ID: 27224013
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
